Supplier Type
- Trader
- contract manufacturer
- Manufacturer
- custom synthesis
- Reagent
Supplier Region
- Mumbai(50)
- Hyderabad(29)
- Ahmedabad(14)
- Maharashtra(28)
- Beijing(1)
- Gujarat(27)
- Vadodara(8)
- Himachal Pradesh(1)
- Bangalore(2)
- Pune(7)
- Karnataka(5)
- Punjab(2)
- Haryana(7)
- New Delhi(5)
- Delhi(10)
- Kolkata(3)
- Andhra Pradesh(2)
- Tamil Nadu(1)
- Uttar Pradesh(4)
- Telangana(3)
- Madhya Pradesh(2)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- more than 95%
- more than 90%
- Min. 99.0%
- Min 99%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Magnesium content 8.49% to 8.84%
- Greater than 99%
- Empagliflozin intermediate, Dapagliflozin Impurity
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- 99.99%
- 99.98%
- 99.95%
- 99.93%
- 99.91%
- 99.90%
- 99.9%
- 99.9 %
- 99.86%
- 99.85%
- 99.84%
- 99.80%
- 99.8%
- 99.73%
- 99.68%
- 99.55%
- 99.50%
- 99.42%
- 99.34%
- 99.30%
- 99.29%
- 99.05%
- 99.0%
- 99% HPLC
- 99%
- >99%
- > 99%
- 99
- 98+
- 98.91%
- 98.70%
- 98.60%
- 98.58%
- 98.57%
- 98.50%
- 98.5 to 101.5%
- 98.20%
- 98.12%
- 98.00%
- 98.0% to 101.0%
- 98.0%
- 98.0 % -102.0 %
- >98%
- 98%
- 98 %
- 98 - 102
- 98
- 97-99%
- 97.57%
- 97.33%
- 97.00%
- 97%
- >97%
- 97 %
- 96-98%
- 96.80%
- 96.64%
- 96.40%
- 96.39%
- 96.25%
- 96.14%
- 96%
- 95.48%
- 95.00%
- 95% min
- >95%
- 95%
- 95 %
- 94.25%
- 94.00%
- 94 - 102
- 93.21%
- 93 %- 101%
- 92.60%
- >92%
- >90%
- 90%
- 90 % Above
- 65%
- 20%
- 2.0M
- 100%
- 1.8M
- 1.0M
- 0.5M
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 100mg
- 11Between 1 gm to 1 MT (As per availability)
- 0MG TO GRAM
- 25mg
- 50mg
- 250mg
- 500mg
- 1g
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100g
- 100gm
- 500g
- 500ml
- 1kg
- 1L
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 250250 mg.
-
Sodium propylparaben
35285-69-9
-
2-Propyl-1H-imidazole-4,5-dicarboxy acid
58954-23-7
-
CONDURITOL B EPOXIDE
6090-95-5
-
Montelukast Acyl-b-D-glucuronide
188717-17-1
-
2-n-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole
152628-02-9
-
10,11-Dihydro-11-oxodibenzo[b,f][1,4]thiazepine
3159-07-7
-
(R)-4-Propyldihydrofuran-2(3H)-one
63095-51-2
-
Bekanamycin
4696-76-8
-
Carbon Black
1333-86-4
-
Sodium citrate
68-04-2
Sodium Propyl Hydroxybenzoate 35285-69-9
2-Propyl-1H-imidazole-4,5-dicarboxylic acid 58954-23-7
Conduritol b epoxide 6090-95-5
2-Propyl-4-methyl-6-(1-methylbenzimidazole-2-yl)benzimidazole 152628-02-9
Dibenzo[b,f][1,4]-thiazepin-11(10H)-one 3159-07-7
(R)-Dihydro-4-propyl-2(3H)-furanone 63095-51-2
Kanamycin B 4696-76-8
Carbon black 1333-86-4
Ciprofloxacin hydrochloride 93107-08-5
Sodium Propyl Hydroxybenzoate 35285-69-9

